Supplementary Table S4 from Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma
Year: 2025
Type: supplementary-materials
Abstract: Pharmacokinetic parameters of JEN-101.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4408133373
